
DAPSONE 6% / NIACINAMIDE 2% / SPIRONOLACTONE 5%
D Sincerus Florida. LLC. Adverse reactions z Active, inactive s NDC 72934-1061-2 DAPSONE USP 6% / NIACINAMIDE USP 2% / SPIRONOLACTONE USP 5%. Gel 30gm sf.
D Sincerus Florida. LLC. Adverse reactions z Active, inactive s NDC 72934-1061-2 DAPSONE USP 6% / NIACINAMIDE USP 2% / SPIRONOLACTONE USP 5%. Gel 30gm sf.
Wr Sincerus Flroida. LLC, adverse reactions w Active. Inactive dgv NDC 72934-1062-2. DAPSONE USP 6%/ NIACINAMIDE USP 2% / TRETINOIN USP 0.025%. Gel30gm zsfd.
G Sincerus Florida. LLC adverse reactions.d Active, inactive d NDC 72934-1063-2 DAPSONE 6 / NIACINAMIDE 4 Gel 30gm f.
De Sincerus Florida. LLC. Adverse reactions dx Active, inactive dw NDC 72934-1064-2 DAPSONE USP 8.5% / NIACINAMIDE USP 2% / SPIRONOLACTONE USP 5%. Gel 30gm a.
H Sincerus Florida. LLC adverse reactions d Active, inactive j NDC 72934-1065-2 DAPSONE 8.5% / NIACINAMIDE 2% / TRETINOIN 0.025% GEL 30 gm c.
As the leading independent provider of trustworthy medication information, we source our database directly from the FDA's central repository of drug labels and package inserts under the Structured Product Labeling standard. Our material is not intended as a substitute for direct consultation with a qualified health professional.
Terms of Use | Copyright © 2021. All Rights Reserved.